Trials / Unknown
UnknownNCT02083900
Use of Banana Leaf Dressing on Donor Site Wounds
Use of Banana Leaf Dressing on Donor Site Wounds: A Prospective Randomized Control Study
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- University of the Philippines · Academic / Other
- Sex
- All
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
Prospective Randomized double-blind controlled trial comparing the healing rate, infection rate, pain score, ease of care and scar formation of Banana leaf dressing versus hydrocolloid dressing.
Detailed description
Prospective Randomized double-blind controlled trial comparing the healing rate, infection rate, pain score, ease of care and scar formation of Banana leaf dressing versus hydrocolloid dressing. Adult patients with no uncontrolled medical condition admitted at Philippine General Hospital Burn Center requiring split thickness skin graft for their burn. this is to compare the efficacy and safety of Banana Leaf Dressing with Hydrocolloid dressing among patients undergoing split thickness skin graft for their burn.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Banana Leaf Dressing | Banana leaf dressing will be prepared by cutting the mid rib of the leaf cutting the leaf into standard size of 12 x 12 inches to facilitate packing. The leaves are rolled and packed in polypropelene bags and subject to gamma irradiation or packed in paper bags for autoclaving. The Banana Leaf Dressing site will receive a single layer of banana leaf without any topical antibiotic applied to the wound followed by a layer of dry gauze for absorption of exudates. The dressing is secured with cling wrap to maintain an occlusive environment. This is then covered by rolled gauze and elastic bandage. |
| DRUG | Hydrocolloid Dressing (DuoDERM CGF) | The donor under HCD was covered with hydrocolloid (DuoDERM CGF). The hydrocolloid dressing was cut to the size of the donor site with an overlap of at least 2 centimeter around the wound edge. After pulling off the adhesive backing, care was taken to ensure that the adhesive was in direct contact with the raw surface. This was likewise covered with a top dressing of gauze for absorption of exudates and an elastic bandage to secure dressing. |
Timeline
- Start date
- 2006-10-01
- Primary completion
- 2007-09-01
- First posted
- 2014-03-11
- Last updated
- 2020-04-24
Locations
1 site across 1 country: Philippines
Source: ClinicalTrials.gov record NCT02083900. Inclusion in this directory is not an endorsement.